The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
March 30, 2021
Early View Perspective COVID-19
Vivian V. Altiery De Jesus
Sabrina A. Assoumou
Back to The Milbank Quarterly
The pandemic has highlighted and exacerbated health inequities in both acute coronavirus disease 2019 (COVID-19) and its longer-term sequelae. Symptoms of COVID-19 persist in approximately one in 10 patients. Acute symptoms include shortness of breath, cough, myalgias, disturbances in the sense of taste and smell, fatigue, fever, chills, and, less commonly, rhinitis and gastrointestinal symptoms. By contrast, the term “long COVID,” coined by patients, refers to both postacute symptoms (lasting more than three weeks) and chronic symptoms (lasting more than 12 weeks). Long COVID is a multisystem disease of unknown cause whose manifestations, while partially overlapping the acute presentation, vary widely among patients and are exacerbated by comorbidities and vulnerabilities. It occurs in adults who were hospitalized and those who were not and (more rarely) in children. At the time of this writing, the United States had more than 17 million diagnosed cases of COVID-19, which translates into approximately 1,700,000 people with long COVID. This does not include the likely underreporting of COVID-19 cases, the proportion of which in one study ranged from one in three to one in 406. The implications for health services are substantial. Given the heterogeneity in definitions of long COVID and the lack of centralized registries of patients with the disease, those who might suffer from long-term symptoms might mistakenly be recorded as recovered.
The natural history of long COVID appears to be gradual improvement over time in most cases, though recovery is typically measured in months. Some patients require comprehensive assessment to exclude serious complications that might underlie their symptoms (notably, thrombo-embolic disease of the lungs, heart, and brain), along with holistic clinical intervention and follow-up. Patients without concerning symptoms should be supported but spared overinvestigation and overmedicalization. Those who have survived admission to an intensive care unit and those with preexisting respiratory, cardiovascular, or cerebrovascular disease are likely to require more specialized and prolonged rehabilitation. Given the paucity of evidence, it is currently unclear which of these issues related to long COVID are directly related to or caused by the disease itself and which are unrelated but may be made more difficult to treat owing to COVID-19 and its after-effects.
Apr 6, 2021
Mar 30, 2021
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, political, historical, legal, and ethical dimensions of health and health care policy.